Halozyme Therapeutics

$42.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+0.44%) Today
-$0.01 (-0.02%) As of 8:04 PM UTC after-hours

Why Robinhood?

You can buy or sell HALO and other stocks, options, and ETFs commission-free!

About HALO

Halozyme Therapeutics, Inc. Common Stock, also called Halozyme Therapeutics, is a biopharmaceutical company, which engages in research, development and commercialization of human enzymes and drug candidates.

CEO
Helen I. Torley
Employees
136
Headquarters
San Diego, California
Founded
1998
Market Cap
6.21B
Price-Earnings Ratio
46.87
Dividend Yield
—
Average Volume
1.32M
High Today
$43.46
Low Today
$42.02
Open Price
$43.01
Volume
856.83K
52 Week High
$56.40
52 Week Low
$17.74

HALO Earnings

-$0.24
$0.02
$0.27
$0.53
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

LCAPU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure